Home > Drug Category > Cancer Medications > Zykadia and Equivalent > Zykadia 150 mg

Brand Zykadia 150 mg from Canada by Novartis

The brand Zykadia 150 mg comes from Canada manufactured by Novartis. It is available in the quantity of 150 capsules.

Zykadia (Ceritinib) Information

Zykadia, which contains the active ingredient ceritinib, is a targeted therapy medication, a second-generation ALK (anaplastic lymphoma kinase) inhibitor. It is primarily used to treat adults with metastatic non-small cell lung cancer (NSCLC) whose tumours are "ALK-positive". This means the cancer cells have a specific genetic rearrangement that drives their growth. The medication is taken by mouth as a tablet or capsule, typically 450 mg (three 150 mg tablets/capsules) once daily with food, though this varies by prescription. In the past, Zykadia was taken on an empty stomach, but current guidelines generally recommend taking it with food to reduce the risk of stomach-related side effects. It is important to take it at the same time each day to maintain steady blood levels.

The mechanism of action involves blocking the activity of the mutated ALK protein. In ALK-positive lung cancer, this protein is overactive, sending constant signals to cancer cells to divide and spread. By binding to this protein and blocking those signals, Zykadia can shrink tumours or slow tumour progression, even if the cancer has spread to the brain.

If you have any questions about placing your order, contact us at our toll-free service at 1.877.223.9977. Our dedicated toll-free customer service representative will help provide support from Monday to Friday 5:30am to 6:00pm and weekends Saturday/Sunday 7:00am to 3:30pm (PST).

Do I need a prescription to order Zykadia 150 mg ?

Yes, a prescription is required from your physician to order Zykadia 150 mg.